New Market Research Report: Sri Lanka Pharmaceuticals & Healthcare Report Q3 2013
Increased longevity in developed markets translates into increased demand for healthcare services and medicines for the elderly. However, in emerging markets such as Sri Lanka, despite increased life expectancy, communicable diseases will remain a significant health burden over the next two decades. This will continue to limit revenue-earning opportunities for companies whose product portfolios contain medicines for the treatment of long-term diseases.
View full press release